chr20-48963810-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006420.3(ARFGEF2):c.839-20A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.333 in 1,610,356 control chromosomes in the GnomAD database, including 91,884 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.37 ( 11502 hom., cov: 31)
Exomes 𝑓: 0.33 ( 80382 hom. )
Consequence
ARFGEF2
NM_006420.3 intron
NM_006420.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0990
Genes affected
ARFGEF2 (HGNC:15853): (ADP ribosylation factor guanine nucleotide exchange factor 2) ADP-ribosylation factors (ARFs) play an important role in intracellular vesicular trafficking. The protein encoded by this gene is involved in the activation of ARFs by accelerating replacement of bound GDP with GTP and is involved in Golgi transport. It contains a Sec7 domain, which may be responsible for its guanine-nucleotide exchange activity and also brefeldin A inhibition. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 20-48963810-A-G is Benign according to our data. Variant chr20-48963810-A-G is described in ClinVar as [Benign]. Clinvar id is 259981.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-48963810-A-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.537 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARFGEF2 | NM_006420.3 | c.839-20A>G | intron_variant | ENST00000371917.5 | NP_006411.2 | |||
ARFGEF2 | NM_001410846.1 | c.839-20A>G | intron_variant | NP_001397775.1 | ||||
ARFGEF2 | XM_047439832.1 | c.275-20A>G | intron_variant | XP_047295788.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARFGEF2 | ENST00000371917.5 | c.839-20A>G | intron_variant | 1 | NM_006420.3 | ENSP00000360985.4 |
Frequencies
GnomAD3 genomes AF: 0.374 AC: 56813AN: 151710Hom.: 11484 Cov.: 31
GnomAD3 genomes
AF:
AC:
56813
AN:
151710
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.310 AC: 77691AN: 250864Hom.: 12813 AF XY: 0.307 AC XY: 41635AN XY: 135582
GnomAD3 exomes
AF:
AC:
77691
AN:
250864
Hom.:
AF XY:
AC XY:
41635
AN XY:
135582
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.328 AC: 478717AN: 1458528Hom.: 80382 Cov.: 31 AF XY: 0.326 AC XY: 236298AN XY: 725766
GnomAD4 exome
AF:
AC:
478717
AN:
1458528
Hom.:
Cov.:
31
AF XY:
AC XY:
236298
AN XY:
725766
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.375 AC: 56882AN: 151828Hom.: 11502 Cov.: 31 AF XY: 0.366 AC XY: 27162AN XY: 74188
GnomAD4 genome
AF:
AC:
56882
AN:
151828
Hom.:
Cov.:
31
AF XY:
AC XY:
27162
AN XY:
74188
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
968
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at